DXB

Dimerix Limited

1 day chart

About DXB

Dimerix Limited (DXB) is a biopharmaceutical company developing new therapies in areas with unmet medical needs. Dimerix pursues new product concepts and applies scientific knowledge to the discovery of products from early-stage development through to commercialisation. Receptor-HIT is licensed non-exclusively to Excellerate Bioscience, a UK-based pharmacological assay service provider with a worldwide reputation for excellence in the field of molecular and cellular pharmacology.

Buy Australian shares starting with DXB. Invest today with a CHESS-sponsored broker!

Sector

Health Care

CEO

Industry

Biotechnology

Website

dimerix.com

Market Capitalisation

$39M

Price-earnings ratio

-3.37

Dividend yield

0.00%

High today

$0.12

Low today

$0.12

Open price

$0.12

52-week high

$0.19

52-week low

$0.11

Announcements

DXB FAQs

How much is one share of Dimerix Limited?

One share of Dimerix Limited is valued at $0.12.

What is the ticker symbol for Dimerix Limited?

The ticker symbol for Dimerix Limited is DXB.

How do I buy DXB shares in Australia?

To buy DXB stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in DXB

What is the 52-week high for Dimerix Limited stock?

The Dimerix Limited 52-week high stock price is $0.19.

What is the 52-week low for Dimerix Limited stock?

The Dimerix Limited 52-week low stock price is $0.11.

What is the market capitalisation of Dimerix Limited DXB?

As of 29/03/2023 Dimerix Limited has a market cap of $39M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.